UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease

Frontiers in molecular neuroscience, 2018-01, Vol.11, p.10-10

2018

Volltextzugriff (PDF)

CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?

Cell & bioscience, 2021-01, Vol.11 (1), p.14-14, Article 14

2021

Volltextzugriff (PDF)

Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis

Metabolites, 2022-07, Vol.12 (8), p.709

2022

Volltextzugriff (PDF)

Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis

PloS one, 2016-08, Vol.11 (8), p.e0161816-e0161816

2016

Volltextzugriff (PDF)

A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis

EMBO molecular medicine, 2015-05, Vol.7 (5), p.526-546

2015

Volltextzugriff (PDF)

Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis

Scientific reports, 2016-11, Vol.6 (1), p.37968-37968, Article 37968

2016

Volltextzugriff (PDF)

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis

Frontiers in neurology, 2019-03, Vol.10, p.191-191

2019

Volltextzugriff (PDF)

A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration

Nature communications, 2024-02, Vol.15 (1), p.1508-1508, Article 1508

2024

Volltextzugriff (PDF)

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target

iScience, 2020-05, Vol.23 (5), p.101087-101087, Article 101087

2020

Volltextzugriff (PDF)

Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients

Stem cell research, 2024-08, Vol.78 (C), p.103447, Article 103447

2024

Volltextzugriff (PDF)

Generation of a human induced pluripotent stem cell line (UQi001-A-1) edited with the CRISPR-Cas9 system to carry the heterozygous TARDBP c.1144G > A (p.A382T) missense mutation

Stem cell research, 2023-08, Vol.70, p.103137-103137, Article 103137

2023

Volltextzugriff (PDF)

Solving the α-Conotoxin Folding Problem: Efficient Selenium-Directed On-Resin Generation of More Potent and Stable Nicotinic Acetylcholine Receptor Antagonists

Journal of the American Chemical Society, 2010-03, Vol.132 (10), p.3514-3522

2010

Volltextzugriff (PDF)

Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression

Neuro-degenerative diseases, 2016-01, Vol.16 (5-6), p.382-397

2016

Volltextzugriff (PDF)

Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?

Cells (Basel, Switzerland), 2021-06, Vol.10 (6), p.1449

2021

Volltextzugriff (PDF)

Lipids: Key players in central nervous system cell physiology and pathology

Seminars in cell & developmental biology, 2021-04, Vol.112, p.59-60

Ngo, Shyuan T.

2021

Volltextzugriff (PDF)

Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1

Genome medicine, 2022-01, Vol.14 (1), p.7-7, Article 7

2022

Volltextzugriff (PDF)

Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis

Brain communications, 2020-09, Vol.2 (2), p.fcaa154-fcaa154

2020

Volltextzugriff (PDF)

Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease

Acta neuropathologica communications, 2022-04, Vol.10 (1), p.61-61, Article 61

2022

Volltextzugriff (PDF)

Skeletal muscle in amyotrophic lateral sclerosis

Brain (London, England : 1878), 2023-11, Vol.146 (11), p.4425-4436

2023

Volltextzugriff (PDF)

Prognostic value of weight loss in patients with amyotrophic lateral sclerosis

Journal of neurology, neurosurgery and psychiatry, 2020-08, Vol.91 (8), p.813

2020

Volltextzugriff (PDF)

Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases

Seminars in cell & developmental biology, 2021-04, Vol.112, p.82-91

2021

Volltextzugriff (PDF)

The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction

Pharmacological reviews, 2024-03, Vol.76 (2), p.300

2024

Volltextzugriff (PDF)

Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2021-04, Vol.22 (3-4), p.161-169

2021

Volltextzugriff (PDF)

Ghrelin as a treatment for amyotrophic lateral sclerosis

Journal of neuroendocrinology, 2021-07, Vol.33 (7), p.e12938-n/a

2021

Volltextzugriff (PDF)

Endocrine rhythms of growth hormone release: Insights from animal studies

Baillière's best practice & research. Clinical endocrinology & metabolism, 2017-12, Vol.31 (6), p.521-533

2017

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(65)
Buchkapitel
(1)

Sprache

Englisch
(66)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(48)
Amyotrophic Lateral Sclerosis
(38)
Neurosciences & Neurology
(27)
Humans
(25)
Clinical Neurology
(20)
Animals
(19)
Neurosciences
(18)
Metabolism
(16)
Mice
(11)
Neurodegenerative Diseases
(10)
Cell Biology
(9)
Motor Neurone Disease
(9)
Als
(8)
Disease Progression
(8)
Male
(8)
Mitochondria
(8)
Patients
(8)
Amyotrophic Lateral Sclerosis - Genetics
(7)
Biochemistry & Molecular Biology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease

CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?

Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis

Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis

A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis

Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis

Biomarkers of Metabolism in Amyotrophic Lateral Sclerosis

A transient protein folding response targets aggregation in the early phase of TDP-43-mediated neurodegeneration

Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target

Generation of human induced pluripotent stem cell lines from sporadic, sporadic frontotemporal dementia, familial SOD1, and familial C9orf72 amyotrophic lateral sclerosis (ALS) patients

Generation of a human induced pluripotent stem cell line (UQi001-A-1) edited with the CRISPR-Cas9 system to carry the heterozygous TARDBP c.1144G > A (p.A382T) missense mutation

Solving the α-Conotoxin Folding Problem: Efficient Selenium-Directed On-Resin Generation of More Potent and Stable Nicotinic Acetylcholine Receptor Antagonists

Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression

Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?

Lipids: Key players in central nervous system cell physiology and pathology

Functional characterisation of the amyotrophic lateral sclerosis risk locus GPX3/TNIP1

Altered skeletal muscle glucose–fatty acid flux in amyotrophic lateral sclerosis

Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease

Skeletal muscle in amyotrophic lateral sclerosis

Prognostic value of weight loss in patients with amyotrophic lateral sclerosis

Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases

The Arylamine N-Acetyltransferases as Therapeutic Targets in Metabolic Diseases Associated with Mitochondrial Dysfunction

Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review

Ghrelin as a treatment for amyotrophic lateral sclerosis

Endocrine rhythms of growth hormone release: Insights from animal studies

Suchergebnisse filtern